Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05912608 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05912608 · ClinicalTrials.gov record · last posted 2026-05-19

Optimal Strategy for Repair of Type A Acute Aortic Dissection

Study acronym: TARAD
StatusEnrolling by Invitation
PhaseNot applicable
Started2024-01-01
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Acute type A aortic dissection (TAAD) persists as a clinicopathologic entity with high lethality in the current era. Several procedures are presently used to repair the TAAAD. The objective of this study is to analyze two groups of individuals using a conservative approach through root-sparing and hemiarch techniques in patients who are hospitalized in higher-risk clinical conditions or more aggressive procedures such as root replacement and total arch replacement in low-risk patients.

Amendment record 9 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 9 times since 2023-06-20; most recent amendment 2026-05-16. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2023-11-07
Status change Not Yet Recruiting→Enrolling by Invitationv1
Trial Details
NCT Number NCT05912608
Lead Sponsor Centre Cardiologique du Nord
Collaborators: Henri Mondor University Hospital, Universita degli Studi di Genova, Pitié-Salpêtrière Hospital, Ospedale San Camillo, Rome, Italy
Conditions Aortic Dissection
Enrollment 900 participants
Start Date 2024-01-01
Primary Completion 2025-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-19